Evidence map›Paper›PMID 40847803›Full record

ArticleAmerican journal of hematology2026

Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy.

Andrea Duminuco, Alessandra Venanzi, Alessia Santi, Alessandro Mancini, Alessandra Romano, Enrico Tiacci

Abstract readCase Reports
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea DuminucoInstitute of Hematology, University and Hospital of Catania, Catania, Italy.ORCID https://orcid.org/0000-0002-9510-4755
Alessandra VenanziInstitute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
Alessia SantiInstitute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
Alessandro ManciniInstitute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.ORCID https://orcid.org/0000-0001-9144-8764
Alessandra RomanoInstitute of Hematology, University and Hospital of Catania, Catania, Italy.ORCID https://orcid.org/0000-0002-6333-4433
Enrico TiacciInstitute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.ORCID https://orcid.org/0000-0001-8055-0931

Funding

Fondazione AIRC per la ricerca sul cancro ETS 21198HCL Foundation and Leukemia/Lymphoma Society HCL8029-22
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hairy cell leukemiaMAP2K1 mutationneoplasia‐lymphoid leukemiasneoplasia‐pharmacotherapeuticstargeted therapy

Identifiers

PMID40847803
PMCPMC12766360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.